Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze FMX stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate FMX investment potential.

What is FMX stock price today?

Get real-time FMX stock price, historical data, and price charts on Financhill. Track FMX performance with our advanced analysis tools.

Is FMX a good investment?

Evaluate FMX investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy FMX stock?

To buy FMX stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of FMX?

View detailed market capitalization data and company valuation metrics for FMX on our comprehensive analysis page.

What is the P/E ratio of FMX?

Use our fundamental analysis tools to view FMX P/E ratio and compare valuation metrics with industry peers.

What are FMX earnings?

View FMX earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Fomento Economico Mexicano SAB de CV 10K Form

Buy

FMX
Fomento Economico Mexicano SAB de CV

Last Price:

$101.35

Seasonality Move:

6.9%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive FMX News And Ratings

See the #1 stock for the next 7 days that we like better than FMX

FMX Financial Statistics

Sales & Book Value

Annual Sales:	$42.6B
Cash Flow:	$362.4M
Price / Cash Flow:	22.18
Annual Sales:	$39.92
Price / Book:	22.98

Profitability

EPS (TTM):	2.56800
Net Income (TTM):	$1.5B
Gross Margin:	$17.4B
Return on Equity:	8.02%
Return on Assets:	3.44%

Fomento Economico Mexicano SAB de CV Earnings Forecast

Key Fomento Economico Mexicano SAB de CV Financial Ratios

The Gross Profit Margin over the past 45 years for FMX is 40.81%.
The Selling, General & Administrative Expenses for FMX have been equal to 32.12% of Gross Profit Margin.
The Research & Development expenses have been 0.00% of Revenue.
The Interest Expense is 40.45% of Operating Income.
The Net Earning history of FMX is 5.13% of Total Revenues.
Per Share Earnings over the last 45 years have been positive in 12 years.

Fomento Economico Mexicano SAB de CV Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NYSE
Industry:	Beverages
Sector:	Consumer Staples
Current Symbol:	FMX
CUSIP:	344419
Website:	femsa.com

Debt

Debt-to-Equity Ratio:	1.05
Current Ratio:	1.34
Quick Ratio:	0.72

Price-to-Earnings

Trailing P/E Ratio:	28.87
Forward P/E Ratio:	22.21

FMX Technical Analysis vs Fundamental Analysis

Buy

Fomento Economico Mexicano SAB de CV (FMX) is a Buy

Is Fomento Economico Mexicano SAB de CV a Buy or a Sell?

Fomento Economico Mexicano SAB de CV stock is rated a Buy

The current Fomento Economico Mexicano SAB de CV [FMX] share price is $102.28. The Score for FMX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.